During the past decade, Shore Health Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shore Health Group" are "Ulcerative Colitis" (2 trials) and "Inflammatory Bowel Disease" (1 trials). Many other conditions were trialed in "Shore Health Group" in a lesser frequency.

Most popular intervention types in "Shore Health Group" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Balsalazide Disodium" (1 trials) and "Encapsulated Mesalamine Granules (eMG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shore Health Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Shore Health Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Shore Health Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shore Health Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".